1. The Role of Free and Cued Selective Reminding Test in Predicting [18F]Florbetaben PET Results in Mild Cognitive Impairment and Mild Dementia.
- Author
-
Spallazzi, Marco, Michelini, Giovanni, Barocco, Federica, Dieci, Francesca, Copelli, Sandra, Messa, Giovanni, Scarlattei, Maura, Pavesi, Giovanni, Ruffini, Livia, and Caffarra, Paolo
- Subjects
MILD cognitive impairment ,DEMENTIA ,ALZHEIMER'S disease ,NEUROPSYCHOLOGICAL tests ,COGNITION disorders ,MEMORY ,DISEASE progression ,RESEARCH ,RESEARCH evaluation ,PREDICTIVE tests ,RESEARCH methodology ,MEDICAL cooperation ,EVALUATION research ,AMINES ,STILBENE ,COMPARATIVE studies ,RADIOPHARMACEUTICALS ,BODY burden ,PROMPTS (Psychology) ,LONGITUDINAL method ,CEREBRAL amyloid angiopathy - Abstract
Background: Free and Cued Selective Reminding Test (FCSRT) is a reliable cognitive marker for Alzheimer's disease (AD), and the identification of neuropsychological tests sensitive to the early signs of AD pathology is crucial both in research and clinical practice.Objective: The study aimed to ascertain the ability of FCSRT in predicting the amyloid load as determined from amyloid PET imaging (Amy-PET) in patients with cognitive disorders.Methods: For our purpose, 79 patients (71 MCI, 8 mild dementia) underwent a complete workup for dementia, including the FCSRT assessment and a [18F]florbetaben PET scan. FCSRT subitem scores were used as predictors in different binomial regression models.Results: Immediate free recall and delayed free recall were the best predictors overall in the whole sample; whereas in patients <76 years, all models further improved with immediate total recall (ITR) and Index of Sensitivity of Cueing (ISC) resulting the most accurate in anticipating Amy-PET results, with a likelihood of being Amy-PET positive greater than 85% for ITR and ISC scores of less than 25 and 0.5, respectively.Conclusion: FCSRT proved itself to be a valid tool in dementia diagnosis, also being able to correlate with amyloid pathology. The possibility to predict Amy-PET results through a simple and reliable neuropsychological test might be helpful for clinicians in the dementia field, adding value to a paper and pencil tool compared to most costly biomarkers. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF